GERN logo

GERN
Geron Corp.

21,369
Mkt Cap
$1.06B
Volume
33.58M
52W High
$2.01
52W Low
$1.04
PE Ratio
-12.90
GERN Fundamentals
Price
$1.66
Prev Close
$1.66
Open
$1.61
50D MA
$1.57
Beta
1.24
Avg. Volume
18.49M
EPS (Annual)
-$0.1252
P/B
4.70
Rev/Employee
$712,717.05
$771.77
Loading...
Loading...
News
all
press releases
Geron (NASDAQ:GERN) Trading Up 9.7% - What's Next?
Geron (NASDAQ:GERN) Stock Price Up 9.7% - Here's Why...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Geron (NASDAQ:GERN) Share Price Passes Above 200 Day Moving Average - What's Next?
Geron (NASDAQ:GERN) Shares Pass Above 200-Day Moving Average - Should You Sell...
MarketBeat·4d ago
News Placeholder
Geron (NASDAQ:GERN) Trading Up 8.6% - Here's What Happened
Geron (NASDAQ:GERN) Trading Up 8.6% - Here's What Happened...
MarketBeat·12d ago
News Placeholder
Geron Corporation (NASDAQ:GERN) Given Average Recommendation of "Hold" by Analysts
Shares of Geron Corporation (NASDAQ:GERN - Get Free Report) have been assigned an average rating of "Hold" from the seven analysts that are presently covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and...
MarketBeat·13d ago
News Placeholder
Geron Details RYTELO Growth Plan, $220M-$240M 2026 Sales Guide and MF Trial Catalyst at Barclays Conference
Executives from Geron (NASDAQ:GERN) outlined their commercial priorities for RYTELO (imetelstat) and provided updates on the company's pipeline and financial outlook during a discussion hosted by...
MarketBeat·18d ago
News Placeholder
Geron (NASDAQ:GERN) Shares Up 8.5% - Should You Buy?
Geron (NASDAQ:GERN) Stock Price Up 8.5% - Should You Buy...
MarketBeat·19d ago
News Placeholder
Almitas Capital LLC Buys Shares of 946,323 Geron Corporation $GERN
Almitas Capital LLC bought a new position in Geron Corporation (NASDAQ:GERN - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission...
MarketBeat·20d ago
News Placeholder
Geron (NASDAQ:GERN) Stock Price Passes Above Two Hundred Day Moving Average - Here's What Happened
Geron (NASDAQ:GERN) Stock Price Passes Above 200-Day Moving Average - Here's What Happened...
MarketBeat·21d ago
News Placeholder
Geron (NASDAQ:GERN) Trading Up 10.9% - Here's What Happened
Geron (NASDAQ:GERN) Trading Up 10.9% - Here's What Happened...
MarketBeat·29d ago
News Placeholder
Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?
Reblozyl tops $2.3B in annualized sales, emerging as a key drug for Bristol Myers as demand rises in MDS-related anemia and new study data support expansion.
Zacks·30d ago
<
1
2
...
>

Latest GERN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.